Molecular Partners AG Cash Flow Statement

Financials in millions CHF. Fiscal year is January - December.

Millions CHF. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-58.53	-61.98	117.85	-63.79	-62.76	-36.29
Depreciation & Amortization	2.42	2.42	2.39	2.57	2.89	2.47
Share-Based Compensation	4.31	5.21	5.09	4.09	2.93	2.44
Other Operating Activities	-7.71	-4.65	-6.76	-33.82	27.96	30.19
Operating Cash Flow	-59.51	-59.01	118.57	-90.95	-28.98	-1.19
Capital Expenditures	-0.63	-0.58	-1.18	-0.93	-1.45	-1.03
Change in Investments	55.34	41.62	-100.2	-21	-20.63	-19.37
Other Investing Activities	4.17	3.59	0.25	-0.3	0.34	0.56
Investing Cash Flow	58.88	44.64	-101.12	-22.24	-21.75	-19.84
Share Issuance / Repurchase	0.03	0.03	-0.38	51.76	114.45	1.01
Debt Issued / Paid	-1.2	-1.2	-1.19	-1.18	-1.25	-1.24
Financing Cash Flow	-1.17	-1.17	-1.57	50.58	113.2	-0.23
Net Cash Flow	-5.59	-20.64	16.13	-61.91	58.01	-23.25
Free Cash Flow	-60.14	-59.58	117.39	-91.89	-30.43	-2.22
Free Cash Flow Margin	-894.17%	-846.55%	61.91%	-942.03%	-325.71%	-10.89%
Free Cash Flow Per Share	-1.83	-1.81	3.61	-2.86	-0.95	-

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).